Causaly Ltd

## Causaly was co-founded in 2018 by automation expert Artur Saudabayev and computer scientist, and language enthusiast, Yiannis Kiachopoulos. Our founders believed that by applying machine learning to the world’s scientific literature, they could radically transform the rate of biomedical discovery and progress.

Causaly’s platform transforms the biomedical workflow from one of “search, read, and synthesise” to “ask questions and analyse”. Causaly’s AI reads the entire volume of biomedical literature ever published in seconds and allows anyone to ask extremely complex questions easily and get answers quickly.

Today we are working with some of the world's largest pharmaceutical companies, renowned academics and national institutions including the National Institute of Environmental Health Sciences.

While Causaly is currently focused on the pharmaceutical sector, its technology has a wide range of potential applications, including healthcare, cosmetics, consumer goods and any industry that touches human health.

In an era when Covid has reminded us of the significance of biomedical innovation, Causaly is poised to help unleash the potential of new research for the benefit of humanity.